The controversy around the dead Chief Executive Officer (CEO) of cryptocurrency exchange QuadrigaCX refuses to die down. While initial reports about Gerald Cotten’s death were met with disbelief and suspicion, a death certificate issued by the Rajasthan Government has quelled the suspicions to some extent.
As earlier reported by Crypto-News India, the death certificate was issued by the Government of Rajasthan, India, Directorate of Economics and Statistics indicates that Cotten died on Dec. 9 – the same date given in a Dec. 12 statement of death from a Halifax funeral home filed in the Nova Scotia court by his wife, Jennifer Robertson.
While the Fortis Hospital Jaipur had refrained from commenting on the matter even as the speculations continued to swirl, it has now clarified certain questions that the global cryptocurrency community had or may have had.
A spokesperson from the hospital who goes by the name Pragya, told news portal The New Indian Express, “The patient died here in Fortis and was brought in an extremely critical condition.” She had further added, that Cotten was brought to the facility on December 8, 2018 at 9.45 PM. The hospital had found that the patient had a history of Crohn’s disease and was on monoclonal antibody therapy ( targeted therapy used to treat colon cancer) every 8th week.
The doctors’ team treating him reportedly diagnosed him with a case of septic shock, perforation peritonitis, and intestinal obstruction, because of which his condition deteriorated suddenly on December 9.
A press release said, “At 2:45 pm, Cotten suffered a cardiac arrest but was revived by CPR. he also suffered two subsequent episodes of ventricular tachycardia (fast heart rhythm) for which cardioversion was conducted.”
The release further stated that the patient suffered a second cardiac arrest a few hours after the first one but could not be saved and was declared dead at around 7:26 pm on December 9.
Hopefully, this statement from the hospital should be enough to satisfy the cryptocurrency community.
Liked what you read? Join us on Telegram